[1] |
Isaacs A, Lindenmann J. Virus interference. I. The interferon[J]. Proc R Soc Lond B Biol Sci, 1957, 147(927):258-267.
|
[2] |
徐先军, 谭勇, 王学进. 兽用干扰素的研究进展[J]. 中国动物保健, 2019, 21(7):58-59.
|
|
Xu XJ, Tan Y, Wang XJ. Research progress of interferon for animals[J]. China Animal Heal, 2019, 21(7):58-59.
|
[3] |
吴玉厚, 吴冰洁, 周国利, 等. 干扰素研究进展[J]. 生物学教学, 2007(7):2-4.
|
|
Wu YH, Wu BJ, Zhou GL, et al. Research progress of interferon[J]. Biol Teach, 2007(7):2-4.
|
[4] |
杨志远, 项勋, 段纲, 等. 禽类α干扰素研究进展[J]. 上海畜牧兽医通讯, 2016(1):24-26.
|
|
Yang ZY, Xiang X, Duan G, et al. Research progress of avian interferon alpha[J]. Shanghai J Animal Husb Vet Med, 2016(1):24-26.
|
[5] |
Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex[J]. Nat Immunol, 2003, 4(1):69-77.
pmid: 12483210
|
[6] |
Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R[J]. Nat Immunol, 2003, 4(1):63-68.
pmid: 12469119
|
[7] |
靳维维, 姚文兵, 徐晨. 干扰素λ结构及抗病毒活性研究进展[J]. 国际药学研究杂志, 2013, 40(3):281-285.
|
|
Jin WW, Yao WB, Xu C. Interferon-λ structure and antiviral activity:research advances[J]. J Int Pharm Res, 2013, 40(3):281-285.
|
[8] |
Wan L, Chang TW. Site-specific lipophilic modification of interferon-Α[J]. J Protein Chem, 2002, 21(6):371-381.
doi: 10.1023/A:1021134131250
URL
|
[9] |
戴单单, 朱素燕, 徐萍, 等. α干扰素雾化吸入的研究进展[J]. 中国临床药学杂志, 2020, 29(4):316-318.
|
|
Dai DD, Zhu SY, Xu P, et al. Research progress of interferon-alpha aerosol inhalation[J]. Chin J Clin Pharm, 2020, 29(4):316-318.
|
[10] |
陈诗军, 陈余清. 干扰素与肿瘤相关性研究进展[J]. 临床肺科杂志, 2017, 22(4):735-739.
|
|
Chen SJ, Chen YQ. Research progress on the correlation between interferon and tumor[J]. J Clin Pulm Med, 2017, 22(4):735-739.
|
[11] |
孙静静, 邵军军, 常惠芸. 干扰素作用机制及其在抗口蹄疫病毒中的应用研究进展[J]. 中国畜牧兽医, 2012, 39(1):206-209.
|
|
Sun JJ, Shao JJ, Chang HY. Interferons and its applications in anti-FMDV[J]. China Animal Husb Vet Med, 2012, 39(1):206-209.
|
[12] |
Mayer K, Nellessen C, Hahn-Ast C, et al. Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL[J]. Eur J Haematol, 2016, 97(2):208-210.
doi: 10.1111/ejh.2016.97.issue-2
URL
|
[13] |
Ward SE, Loutfy MR, Blatt LM, et al. Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids[J]. Antivir Ther, 2005, 10(2):263-275.
|
[14] |
Sjogren MH, Sjogren R, Holtzmuller K, et al. Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C[J]. Dig Dis Sci, 2005, 50(4):727-732.
doi: 10.1007/s10620-005-2564-2
URL
|
[15] |
徐丙发, 范清林, 魏伟, 等. 干扰素-α及长效干扰素抗肝炎病毒作用机制的研究进展[J]. 中国药理学通报, 2008, 24(10):1276-1279.
|
|
Xu BF, Fan QL, Wei W, et al. Research progress of the anti-hepatitis virus mechanism of interferon-alpha and long-acting form of interferons[J]. Chin Pharmacol Bull, 2008, 24(10):1276-1279.
|
[16] |
Khalafalla AI, Saeed IK, Ali YH, et al. An outbreak of peste des petits ruminants(PPR)in camels in the Sudan[J]. Acta Trop, 2010, 116(2):161-165.
doi: 10.1016/j.actatropica.2010.08.002
URL
|
[17] |
Banyard AC, Parida S, Batten C, et al. Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control[J]. J Gen Virol, 2010, 91(12):2885-2897.
doi: 10.1099/vir.0.025841-0
URL
|
[18] |
Kumar S, Stecher G, Li M, et al. MEGA X:molecular evolutionary genetics analysis across computing platforms[J]. Mol Biol Evol, 2018, 35(6):1547-1549.
doi: 10.1093/molbev/msy096
URL
|
[19] |
赵璐璐, 赵泽, 杨鑫, 等. 牛λ3干扰素在家蚕杆状病毒表达系统中的表达及其抗病毒活性检测[J]. 生物技术进展, 2018, 8(5):420-425, 466.
|
|
Zhao LL, Zhao Z, Yang X, et al. Expression of bovine λ3 interferon in silkworm-baculovirus expression system and the antiviral activity assay[J]. Curr Biotechnol, 2018, 8(5):420-425, 466.
|
[20] |
Liu X, Wei Y, Li Y, et al. A highly efficient and simple construction strategy for producing recombinant baculovirus Bombyx mori nucleopolyhedrovirus[J]. PLoS One, 2016, 11(3):e0152140.
doi: 10.1371/journal.pone.0152140
URL
|
[21] |
Liu X, Yang X, Mehboob A, et al. A construction strategy for a baculovirus-silkworm multigene expression system and its application for coexpression of type I and type II interferons[J]. Microbiologyopen, 2020, 9(3):e979.
|
[22] |
张军楠, 邵杰, 梁争论. I型干扰素免疫应答作用机制研究进展[J]. 微生物学免疫学进展, 2014, 42(3):54-58.
|
|
Zhang JN, Shao J, Liang ZL. Advances in type I interferon-mediated immune response mechanism[J]. Prog Microbiol Immunol, 2014, 42(3):54-58.
|
[23] |
杨莉萍, 曹素艳, 邵宏. 干扰素的抗病毒作用及其临床应用[J]. 国外医学:药学分册, 2004, 31(2):78-82.
|
|
Yang LP, Cao SY, Shao H. Antiviral effect of interferon and its clinical application[J]. Foreign Med Sci Sect Pharm, 2004, 31(2):78-82.
|